Objectives
To evaluate the influence of facility case‐volume on survival in patients with locally advanced papillary thyroid cancer (PTC), and to identify prognostic case‐volume thresholds for facilities managing this patient population.
Study Design
Retrospective database study.
Methods
The 2004–2017 National Cancer Database was queried for patients receiving definitive surgery for locally advanced PTC. Using K‐means clustering and multivariable Cox proportional‐hazards (CPH) regression, two groups with distinct spectrums of facility case‐volumes were generated. Multivariable CPH regression and Kaplan–Meier analysis assessed for the influence of facility case‐volume and the prognostic value of its stratification on overall survival (OS).
Results
Of 48,899 patients treated at 1304 facilities, there were 34,312 (70.2%) females and the mean age was 48.0 ± 16.0 years. Increased facility volume was significantly associated with reduced all‐cause mortality (HR 0.996; 95% CI, 0.992–0.999; p = 0.008). Five facility clusters were generated, from which two distinct cohorts were identified: low (LVF; <27 cases/year) and high (HVF; ≥27 cases/year) facility case‐volume. Patients at HVFs were associated with reduced mortality compared to those at LVFs (HR 0.791; 95% CI, 0.678–0.923, p = 0.003). Kaplan–Meier analysis of propensity score‐matched N0 and N1 patients demonstrated higher OS in HVF cohorts (all p < 0.001).
Conclusions
Facility case‐volume was an independent predictor of improved OS in locally advanced PTC, indicating a possible survival benefit at high‐volume medical centers. Specifically, independent of a number of sociodemographic and clinical factors, facilities that treated ≥27 cases per year were associated with increased OS. Patients with locally advanced PTC may, therefore, benefit from referrals to higher‐volume facilities.
Level of Evidence
4 Laryngoscope, 133:443–450, 2023